Gene · 5745
Papers2,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism. | J Endocrinol Invest | 2022 | 35751804 | PubTator, text mining | PubMed |
| Evaluation of the Relationship between the BMI and the Sequence and Chronology of Eruption in Permanent Dentition in Spanish Population. | Healthcare (Basel) | 2022 | 35742098 | PubTator, text mining | PubMed |
| Parathyroid Hormone-Related Peptide (PTHrP): Evaluation of Pediatric, Covariate-Stratified Reference Intervals. | Children (Basel) | 2022 | 35740833 | PubTator, text mining | PubMed |
| Teeth Eruption Disorders: A Critical Review. | Children (Basel) | 2022 | 35740708 | PubTator, text mining | PubMed |
| Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma. | Intervirology | 2022 | 35728518 | PubTator, text mining | PubMed |
| The Role of Epigenetic in Dental and Oral Regenerative Medicine by Different Types of Dental Stem Cells: A Comprehensive Overview. | Stem Cells Int | 2022 | 35721599 | PubTator, text mining | PubMed |
| Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or Pseudohypoparathyroidism. | JBMR Plus | 2022 | 35720667 | PubTator, text mining | PubMed |
| Regulation and roles of RNA modifications in aging-related diseases. | Aging Cell | 2022 | 35718942 | PubTator, text mining | PubMed |
| A naturally occurring membrane-anchored Gαs variant, XLαs, activates phospholipase Cβ4. | J Biol Chem | 2022 | 35709985 | PubTator, text mining | PubMed |
| Mechanisms during Osteogenic Differentiation in Human Dental Follicle Cells. | Int J Mol Sci | 2022 | 35682637 | PubTator, text mining | PubMed |
| Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs. | Front Mol Biosci | 2022 | 35677880 | PubTator, text mining | PubMed |
| Structural insights into human brain-gut peptide cholecystokinin receptors. | Cell Discov | 2022 | 35672283 | PubTator, text mining | PubMed |
| 3D-Printed β-Tricalcium Phosphate Scaffolds Promote Osteogenic Differentiation of Bone Marrow-Deprived Mesenchymal Stem Cells in an N6-methyladenosine-Dependent Manner. | Int J Bioprint | 2022 | 35669331 | PubTator, text mining | PubMed |
| Pseudohypoparathyroidism: a diagnosis to consider once a PTH elevation is detected. | Acta Biomed | 2022 | 35666115 | PubTator, text mining | PubMed |
| Vascular Calcification in Chronic Kidney Disease: An Update and Perspective. | Aging Dis | 2022 | 35656113 | PubTator, text mining | PubMed |
| Assessment of the Therapeutic Potential of Melatonin for the Treatment of Osteoporosis Through a Narrative Review of Its Signaling and Preclinical and Clinical Studies. | Front Pharmacol | 2022 | 35645810 | PubTator, text mining | PubMed |
| Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? | Chem Soc Rev | 2022 | 35642539 | PubTator, text mining | PubMed |
Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway. | Bioengineered | 2022 | 35635031 | PubTator, text mining | PubMed |
| Shedding Light on the Complex Regulation of FGF23. | Metabolites | 2022 | 35629904 | PubTator, text mining | PubMed |
| A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients. | Front Pharmacol | 2022 | 35614936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5745/papers?page=28